Conclusion: Among patients previously treated with definitive EBRT, salvage LDR brachytherapy for localized intra-prostatic recurrence was safe with an acceptable rate of grade 3+ toxicity. Additionally, salvage LDR brachytherapy proved efficacious with 62% of patients remaining disease free at 5 years. Additional patients and longer follow-up are needed to confirm these results.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.